Kato Michitaka, Sakurada Koji, Saitoh Masakazu, Morisawa Tomoyuki, Iida Yuki, Kamiya Kentaro, Kono Yuji, Taya Masanobu, Iwata Kentaro, Funami Yoshinari, Kito Kazuya, Nakatani Eiji, Takahashi Tetsuya
Department of Shizuoka Physical Therapy, Faculty of Health Science, Tokoha University, Shizuoka, Japan; Committee of the J-Proof HF Registry, Japanese Society of Cardiovascular Physical Therapy, Tokyo, Japan.
Committee of the J-Proof HF Registry, Japanese Society of Cardiovascular Physical Therapy, Tokyo, Japan; Department of Rehabilitation, The Cardiovascular Institute, Tokyo, Japan.
J Am Med Dir Assoc. 2025 Jun;26(6):105549. doi: 10.1016/j.jamda.2025.105549. Epub 2025 May 13.
Hospitalization-associated disability (HAD) is the loss of the ability to perform one of the basic activities of daily living (ADLs) required for independent living during hospitalization. This study aimed to determine whether HAD is a significant prognostic risk factor in older patients with heart failure (HF) and independent ADLs.
Prospective, nationwide, multicenter registry study conducted between December 2020 and March 2022.
This study was conducted across 96 centers in Japan and included 6519 older patients (aged ≥65 years) with HF who were independent in ADL before hospitalization.
HAD was defined as a drop of at least 5 points in the Barthel Index (BI) at discharge, relative to a stable score before hospitalization. Subgroup analysis classified HAD as mild (a decrease of 5-15 points in the BI) and severe (a decrease of ≥20 points in the BI). The primary outcome was all-cause mortality within 1 year after hospital discharge, and the secondary outcomes were HF-related mortality and rehospitalization.
All-cause mortality, HF-related mortality, and rehospitalization rates within 1 year were 12%, 5%, and 41%, respectively. Multivariate Cox regression analysis revealed that HAD increased the risk of 1-year all-cause mortality after hospital discharge (adjusted hazard ratio, 1.749; 95% CI, 1.475-2.075). Subgroup analysis showed a significantly higher risk of all-cause mortality among patients with severe HAD than among those with mild HAD (1.388; 1.109-1.739). HAD was a significant risk factor for HF-related mortality (1.556; 1.216-2.017). However, no relationship was observed between HAD and readmission (1.062; 0.970-1.163).
The development of HAD was identified as a significant risk factor for 1-year post-discharge mortality among older patients with HF who were independent in ADLs before hospitalization. Preventing minor declines in ADL and mitigating any ADL impairments during hospitalization are crucial to avoiding a worsening prognosis.
住院相关失能(HAD)是指在住院期间丧失独立生活所需的一项基本日常生活活动(ADL)能力。本研究旨在确定HAD是否是老年心力衰竭(HF)患者且ADL功能独立的一个重要预后风险因素。
2020年12月至2022年3月期间进行的一项前瞻性、全国性、多中心登记研究。
本研究在日本的96个中心开展,纳入6519例年龄≥65岁、住院前ADL功能独立的老年HF患者。
HAD定义为出院时Barthel指数(BI)相对于住院前稳定评分下降至少5分。亚组分析将HAD分为轻度(BI下降5 - 15分)和重度(BI下降≥20分)。主要结局是出院后1年内的全因死亡率,次要结局是HF相关死亡率和再住院率。
1年内全因死亡率、HF相关死亡率和再住院率分别为12%、5%和41%。多因素Cox回归分析显示,HAD增加了出院后1年全因死亡风险(调整后风险比,1.749;95%置信区间,1.475 - 2.075)。亚组分析显示,重度HAD患者的全因死亡风险显著高于轻度HAD患者(1.388;1.109 - 1.739)。HAD是HF相关死亡率的一个重要风险因素(1.556;1.216 - 2.017)。然而,未观察到HAD与再入院之间的关系(1.062;0.970 - 1.163)。
对于住院前ADL功能独立的老年HF患者,HAD的发生被确定为出院后1年死亡率的一个重要风险因素。预防ADL的轻微下降并减轻住院期间的任何ADL损伤对于避免预后恶化至关重要。